A federal government grant-backed trial in Queensland will be testing an intravenous treatment monitoring system on hospitalised babies.
The monitoring system involves attaching a near-infrared sensor to a baby's skin near the IV site to monitor continuously the surrounding tissues. It sets off alarms when it detects a volume change in those tissues.
WHY IT MATTERS
In Australia, over 18,000...
Australia invests $20M for new health AI projects
The Australian government has awarded 10 AI projects from major universities with nearly A$30 million ($20 million) in total grant funding to improve healthcare access.
These include research from the University of Queensland to trial AI, in tandem with 3D total skin imaging, for early melanoma detection. Another project from the University of...
Funding worth A$6.5 million ($4 million) has been awarded to four genomics-focused research projects led by researchers from the University of Melbourne.
These include a project that will establish a patient dataset of inherited retinal diseases; a rapid multi-omic liquid biopsy blood test using whole genome sequencing; research using next-generation sequencing to develop new solutions to...
The University of Queensland is now expanding its aphasia therapy programme to reach more patients living in rural and regional areas.
A year since it was launched at Metro North Health’s Surgical Treatment and Rehabilitation Service in Brisbane, the Comprehensive High-Dose Aphasia Treatment (CHAT) programme will be tried out in seven hospitals and health service sites in Queensland, New South...
Pfizer completes ResApp purchase for over $115 million
Biopharmaceutical giant Pfizer has finalised its acquisition of ASX-listed digital health startup ResApp for A$179 million ($116 million), according to the University of Queensland.
Brisbane-based ResApp has developed a mobile app that analyses cough sounds and diagnoses respiratory diseases, including asthma, pneumonia, bronchiolitis, croup...
The Queensland Brain Institute under the University of Queensland has developed a remote care platform for monitoring and treating patients with neurological disorders.
WHAT IT DOES
Created in partnership with Neurosciences Queensland and Abbott Neuromodulation, the digital platform allows clinicians to remotely monitor patients and adjust their devices to treat and alleviate their symptoms in...
Researchers from the University of Queensland in Australia have developed shoe insole technology that helps people with foot sensory loss maintain their balance.
WHAT IT DOES
The insole uses bionic technology called Augmented Vibrotexture, a hybrid design combining vibration and geometric texture, to provide sensory stimuli to the soles of the feet. It delivers feedback along major sensory nerves...
In Australia, researchers have developed a tool that determines a person's risk of contracting COVID-19 and complications from vaccines.
Non-profit Immunisation Coalition collaborated with the University of Queensland, Flinders University, La Trobe University, and the Queensland University of Technology to create the COVID-19 Risk Calculator (CoRiCal) tool.
WHAT IT DOES
Users just have to...
An app that essentially elevates coughing into a smartphone into a sophisticated diagnostic tool has performed well again in a clinical study. Australian digital health company ResApp, which makes a smartphone-based tool for diagnosing respiratory conditions, reported 91 to 100 percent accuracy with the app in a study of 243 patients spanning six different respiratory conditions.
The results are...
Academics in Australia at the University of Queensland have launched a three-year research project that will examine the impact of using digital health tools in physical education programs with kids. The project has received $177,000 AUS (about $137,000 US dollars) from the Australian Research Council Discovery Grant and is being conducted in collaboration with researchers in Melbourne and...
